TCL Archive Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival July 27, 2012
TCL Archive In Brief: Day, Foti Lead Coalition; Harkin Ends Campaigns; UT Southwestern Recieves $85 Mil. In Donations March 13, 1992
TCL Archive Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia November 26, 2004